Life ScienceCompany
Celgene M&A Summary
Celgene has acquired 15 companies of its own. It has also divested 3 assets.
Celgene’s largest acquisition to date was in 2018, when it acquired Juno Therapeutics for $9.0B. It’s largest disclosed sale occurred in 2019, when it sold Otezla to Amgen for $13.4B. Celgene has acquired in 5 different US states, and 3 countries. The Company’s most targeted sectors include life science (80%) and medical products (20%).
Celgene Ownership
Who owns Celgene?
Celgene is owned by Bristol-Myers Squibb. It was acquired on January 3, 2019.
Celgene Business Overview
Where is Celgene headquartered?
Celgene is headquartered in Summit, New Jersey.
What is Celgene’s revenue?
Celgene disclosed revenue of 13,003M USD for 2017 and 11,229M USD for 2016.
How many employees does Celgene have?
Celgene has 6,971 employees.
What sector is Celgene in?
Celgene is a life science company.
When was Celgene founded?
Celgene was founded in 1980.
M&A Summary
-
M&A Total Activity18
- M&A Buy Activity15
- M&A Sell Activity3
- Total Sectors Invested 2
- Total Countries Invested 3
- M&A Buy/Sell Connections 5
- M&A Advisors 9
Unlimited Searches
